Unknown

Dataset Information

0

Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.


ABSTRACT: Carbonic anhydrase II (CAII) is a zinc-containing metalloenzyme whose aberrant activity is associated with various diseases such as glaucoma, osteoporosis, and different types of tumors; therefore, the development of CAII inhibitors, which can represent promising therapeutic agents for the treatment of these pathologies, is a current topic in medicinal chemistry. Molecular docking is a commonly used tool in structure-based drug design of enzyme inhibitors. However, there is still a need for improving docking reliability, especially in terms of scoring functions, since the complex pattern of energetic contributions driving ligand⁻protein binding cannot be properly described by mathematical functions only including approximated energetic terms. Here we report a novel CAII-specific fingerprint-based (IFP) scoring function developed according to the ligand⁻protein interactions detected in the CAII-inhibitor co-crystal structures of the most potent CAII ligands. Our IFP scoring function outperformed the ability of Autodock4 scoring function to identify native-like docking poses of CAII inhibitors and thus allowed a considerable improvement of docking reliability. Moreover, the ligand⁻protein interaction fingerprints showed a useful application in the binding mode analysis of structurally diverse CAII ligands.

SUBMITTER: Poli G 

PROVIDER: S-EPMC6073570 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.

Poli Giulio G   Jha Vibhu V   Martinelli Adriano A   Supuran Claudiu T CT   Tuccinardi Tiziano T  

International journal of molecular sciences 20180623 7


Carbonic anhydrase II (CAII) is a zinc-containing metalloenzyme whose aberrant activity is associated with various diseases such as glaucoma, osteoporosis, and different types of tumors; therefore, the development of CAII inhibitors, which can represent promising therapeutic agents for the treatment of these pathologies, is a current topic in medicinal chemistry. Molecular docking is a commonly used tool in structure-based drug design of enzyme inhibitors. However, there is still a need for impr  ...[more]

Similar Datasets

| S-EPMC4505086 | biostudies-literature
| S-EPMC6404860 | biostudies-literature
| S-EPMC4482258 | biostudies-literature
| S-EPMC6009921 | biostudies-literature
| S-EPMC3674230 | biostudies-literature
| S-EPMC9515202 | biostudies-literature
| S-EPMC9822402 | biostudies-literature
| S-EPMC8126098 | biostudies-literature
| S-EPMC8919859 | biostudies-literature
| S-EPMC1751391 | biostudies-literature